Notch is out — your watchlist beside the MacBook notch, synced with this account.
Learn more ↗We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Daily historical data with per-account defaults
Filings, earnings, research, and institutional changes — newest first
EPS 컨센서스 0.63 · 매출 컨센서스 8.6억. 발표 후 실제치와 비교하세요.
EPS 1.26 · 매출 9.3억. 세부 수치와 가이던스는 원문에서 확인하세요.
신규 편입 · 포트폴리오 비중 0.01%
US analyst rating / recommendation change.
EPS 0.84 · 매출 7.9억. 세부 수치와 가이던스는 원문에서 확인하세요.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
매출 12.3억. 세부 수치와 가이던스는 원문에서 확인하세요.
US analyst rating / recommendation change.
EPS 1.25 · 매출 9.8억. 세부 수치와 가이던스는 원문에서 확인하세요.
Consensus vs. actual, and revenue trend
| Quarter | Date | Time | EPS est. | EPS actual | Surprise | Rev. est. | Rev. actual | Status |
|---|---|---|---|---|---|---|---|---|
| — | 2026. 07. 22. | After market close (AMC) | $0.63 | — | — | $855.6M | — | Scheduled |
| FY2026 Q2 | 2026. 06. 30. | Time TBD | — | $1.26 | — | — | $927.23M | Reported |
| FY2026 Q1 | 2026. 03. 31. | Time TBD | — | $0.84 | — | — | $789.67M | Reported |
| FY2025 Q4 | 2025. 12. 31. | Time TBD | — | — | — | — | $1.23B | Reported |
Consensus PT $78 · 2 analysts
| Date | Firm | Analyst | Action | Rating change | Price target | Report |
|---|---|---|---|---|---|---|
| 2026. 04. 30. | JP Morgan | — | Maintain | Underweight → Underweight | — | JP Morgan: Underweight |
| 2026. 02. 03. | JP Morgan | — | Maintain | Underweight → Underweight | — | JP Morgan: Underweight |
| 2026. 01. 21. | Citizens | — | Initiate coverage | — → Market Outperform | — | Citizens: Market Outperform |
| 2025. 12. 04. | JP Morgan | — | Downgrade | Neutral → Underweight | — | JP Morgan: Neutral → Underweight |
| 2025. 07. 01. | B. Riley Securities | — | Initiate coverage | — → Buy | — | B. Riley Securities: Buy |
| 2025. 06. 17. | Texas Capital Securities | — | Initiate coverage | — → Buy | — | Texas Capital Securities: Buy |